Breaking News2 years ago
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
[ad_1] Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion. The pharmaceutical giant announced...
